Biogen Stock Jumps on FDA Approval. What Wall Street Is Saying.
The pop in the stock was even more breath-taking than what analysts had predicted, but seems consistent with the FDA's action, which took even Biogen (ticker: BIIB) bulls by surprise. The news ignited shares of other drugmakers. In afternoon trading on ...
